| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35561-345-11 | 35561-345 | HUMAN PRESCRIPTION DRUG | Fenofibrate | FENOFIBRATE | CAPSULE | ORAL | 20171117 | N/A | ANDA | ANDA207805 | Bostal LLC | FENOFIBRATE | 67 mg/1 | 90 CAPSULE in 1 BOTTLE (35561-345-11) |
| 35561-345-12 | 35561-345 | HUMAN PRESCRIPTION DRUG | Fenofibrate | FENOFIBRATE | CAPSULE | ORAL | 20201120 | N/A | ANDA | ANDA207805 | Bostal LLC | FENOFIBRATE | 67 mg/1 | 100 CAPSULE in 1 BOTTLE (35561-345-12) |
| 35561-346-11 | 35561-346 | HUMAN PRESCRIPTION DRUG | Fenofibrate | FENOFIBRATE | CAPSULE | ORAL | 20171117 | N/A | ANDA | ANDA207805 | Bostal LLC | FENOFIBRATE | 134 mg/1 | 90 CAPSULE in 1 BOTTLE (35561-346-11) |
| 35561-346-12 | 35561-346 | HUMAN PRESCRIPTION DRUG | Fenofibrate | FENOFIBRATE | CAPSULE | ORAL | 20201120 | N/A | ANDA | ANDA207805 | Bostal LLC | FENOFIBRATE | 134 mg/1 | 100 CAPSULE in 1 BOTTLE (35561-346-12) |
| 35561-347-11 | 35561-347 | HUMAN PRESCRIPTION DRUG | Fenofibrate | FENOFIBRATE | CAPSULE | ORAL | 20171117 | N/A | ANDA | ANDA207805 | Bostal LLC | FENOFIBRATE | 200 mg/1 | 90 CAPSULE in 1 BOTTLE (35561-347-11) |
| 35561-347-12 | 35561-347 | HUMAN PRESCRIPTION DRUG | Fenofibrate | FENOFIBRATE | CAPSULE | ORAL | 20201120 | N/A | ANDA | ANDA207805 | Bostal LLC | FENOFIBRATE | 200 mg/1 | 100 CAPSULE in 1 BOTTLE (35561-347-12) |